Komori
Bando Chemical Industries (5195) · PolicyAdvanced

Policy for Reviewing and Reducing Strategic Shareholdings

First written in FY2019. 6 of 7 entries say "Advanced", first in FY2020. Latest entry: FY2026.

7entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019AdvancedFY2020 – FY20262019: 120192020: 120202021: 120212022: 120222023: 120232024: 020242025: 120252026: 12026
Same theme, other companies
Review of the Rationale for Holding Strategic ShareholdingsA theme 1258 companies write about · 1 as a headwind · 666 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 1262 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Issues with a decrease in the number of shares during the fiscal year: shares other than unlisted shares, 2 issues, ¥334 million」

    The review of cross-shareholdings continued, and 2 issues other than unlisted shares were sold for sale proceeds of ¥334 million. In addition, 1 issue of unlisted shares was acquired for ¥49 million for the purpose of collaboration through synergies with technology.
  2. FY2025AdvancedAnnual report

    「Some holdings were also sold during the fiscal year.」

    The review of cross-shareholdings continued, and 2 issues other than unlisted shares were sold for total sale proceeds of ¥326 million.
  3. FY2023AdvancedAnnual report

    「Some holdings were also sold during the fiscal year.」

    The review of cross-shareholdings continued, and 2 issues other than unlisted shares were sold in fiscal 2022 for total sale proceeds of ¥133 million.
  4. FY2022AdvancedAnnual report

    「As a result, we identified some issues for which we will consider selling in the future because of a decline in the significance of the holding or other factors. We also sold some holdings during the fiscal year.」

    The review of cross-shareholdings continued, and 3 issues other than unlisted shares were sold during the fiscal year for total sale proceeds of ¥2,831 million.
  5. FY2021AdvancedAnnual report

    「As a result, we identified some issues for which we will consider selling in the future because of a decline in the significance of the holding or other factors. We also sold some holdings during the fiscal year.」

    The review of cross-shareholdings continued, and 10 issues were sold during the fiscal year for total sale proceeds of ¥920 million.
  6. FY2020AdvancedAnnual report

    「For every individual issue, we verified the status of related income, including dividends and profits from related transactions, compared with the cost of capital on the balance-sheet value. As a result, we confirmed that related income exceeded the cost of capital for most of the issues reviewed. We also confirmed the qualitative significance of each individual holding. As a result, we identified some issues for which we will consider selling in the future because of a decline in the significance of the holding or other factors. Accordingly, we sold some holdings during the fiscal year.」

    Cross-shareholdings were reviewed individually, and after confirming their comparison with the cost of capital and their qualitative significance, some holdings were sold during the fiscal year.
  7. FY2019First statedAnnual report

    「Every year, our Board of Directors reviews cross-shareholdings and examines and verifies, in addition to their compliance with our holding policy, whether the benefits and risks associated with holding them are commensurate with the cost of capital. If it determines that the significance of a holding is limited, it follows a policy of reducing the holding.」

    For cross-shareholdings, the company for the first time expressly stated a policy of annually verifying the comparison with the cost of capital and the qualitative significance of each holding, and reducing holdings with limited significance.
Moved together

"Creating New Businesses and Developing New Markets" moved the same way as this thread, in the same document, in 6 of its 7 moves.

666655★123456
  1. ★This thread
  2. 1Creating New Businesses and Developing New Markets6×
  3. 2Development of Market-Optimized Specifications and High-Value-Added Products6×
  4. 3Globally Optimized Production Structure and Global Cost Competitiveness6×
  5. 4Work-Style Reform for Individuals and Organizations6×
  6. 5Evolution of the Global Market Strategy5×
  7. 6Deliberation on Director Appointments and Compensation by the Nomination and Compensation Committees5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Bando Chemical Industries yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Policy for Reviewing and Reducing Strategic Shareholdings | Bando Chemical Industries,Ltd. (5195) | Komori